I think the most likely response from FDA is a denial to reclassify but they will get answers to limits of human testing need to get approval. A trial with a small number of people for a year or less is very possible. Even this will be a positive step. At least they will know what is required. I think you can expect large preferred share dump soon and some new investors willing to fund the trials.
Everyone but Stupid is smart enough to see this coming. They have no revenue and bills to pay plus Katzaturds large salary. Yes, they should have been selling isotopes for the past year and actually doing something besides dumping more shares but it didn't happen. Reverse split is all but certain as well. Once reverse split happens Katzaturd will have lots more common shares to dump once again also. FDA news better come very soon or this will see triple 000 once again. We have no news or bad news, take your pick.